Clinical Practice Guideline: Screening For Breast Cancer Research
The purpose of this paper is to analyze a current clinical practice guideline (CPG) on breast cancer screenings by the U.S. Preventive Services Task Force (USPSTF). A CPG is a statement that compiles the highest level of evidence-based research from systematic research reviews (SRR) and other research to direct practitioners with appropriate health care interventions (Sriganesh, Shanthanna, & Busse, 2016). This breast cancer CPG’s scope, purpose, stakeholder involvement, rigor of development, clarity, and applicability will be critiqued in detail.
Scope and Purpose of the Clinical Practice Guideline (CPG)
The scope and purpose of the document is for providers in family, internal, or preventative medicine, as well as nursing, obstetrics and gynecology, oncology, and radiology who treat breast cancer. This CPG seeks to answer ten key questions. Some of the questions are about the effectiveness of mammography in relation to reducing breast cancer-specific mortality and prevention of advanced breast cancer by age groups. The authors of the CPG also seek to understand the differences in performance with newer breast screening technologies, issues surrounding dense breast screenings, and harms of current routine screening methods.
The …show more content…
The following electronic databases were searched through 4 June 2015: Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Ovid MEDLINE. Unpublished data from the Canadian National Breast Screening Study and Swedish Two-County Trials were also included. 38 studies including 5 SRRs of 62 studies met inclusion